Bank of America Securities: Lower Agricultural Bank of China (01288) target price to 5.8 Hong Kong dollars, last year's profit slightly below expectations.
This line indicates that Agricultural Bank's net interest margin in the fourth quarter of last year fell by 7 basis points to 1.2% quarter-on-quarter, performing weaker compared to its peers.
Bank of America Securities released a research report stating that considering the downward revision of profit forecasts and a 50 basis point increase in the cost of equity, the profit forecasts for Agricultural Bank of China (01288, 601288.SH) for 2026 and 2027 have been revised downward by 1% to 2%. The target price for the H shares has been adjusted from 6.32 Hong Kong dollars to 5.8 Hong Kong dollars, and the target price for the A shares of Agricultural Bank of China has been adjusted from 7.32 Chinese yuan to 6.4 Chinese yuan. The "neutral" rating for the H shares and the "underperform" rating for the A shares are maintained.
The net profit of Agricultural Bank of China last year increased by 3.2% year-on-year to 291 billion Chinese yuan, slightly lower than the bank's expectations by 0.9%. The core profit decreased slightly by 0.1% year-on-year, lower than expectations by 1.8%. The return on equity dropped by 0.3 percentage points to 10.2% last year, and the core Tier 1 capital adequacy ratio decreased by 35 basis points to 11.08%. The dividend payout ratio remained stable, with a year-on-year increase of 3.1% to 0.2495 yuan per share. The dividend yield for H shares and A shares is 5.2% and 3.8%, respectively, relatively lower among peers.
The bank stated that the net interest margin for Agricultural Bank of China in the fourth quarter of last year fell by 7 basis points quarter-on-quarter to 1.2%, showing weaker performance compared to peers. Fee income increased by 16.6% year-on-year, benefiting from a sharp increase of 88% in agency commissions. Other non-interest income was driven by disposal of debt securities and foreign exchange gains, increasing by 22% year-on-year. Revenue increased by 1.7% year-on-year, while operating costs increased by 4.9%, leading to a 1.1 percentage point increase in the cost-to-income ratio to 37.3%.
Related Articles

MANY IDEA CLOUD (06696) will be suspended from trading starting from March 31st to await the release of insider information and the 2025 annual performance.

Daan Gene Co., Ltd.'s subsidiary obtained a medical device registration certificate.

Galaxy Aerospace initiates A-share IPO guidance Commercial aerospace unicorn sprinting towards the capital market.
MANY IDEA CLOUD (06696) will be suspended from trading starting from March 31st to await the release of insider information and the 2025 annual performance.

Daan Gene Co., Ltd.'s subsidiary obtained a medical device registration certificate.

Galaxy Aerospace initiates A-share IPO guidance Commercial aerospace unicorn sprinting towards the capital market.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


